ONYX PHARMACEUTICALS INC (ONXX) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 959 transactions totaling $126.6M, demonstrating a bearish sentiment with -$126.5M in net insider flow. The most recent transaction on Oct 1, 2013 involved a transaction of 2,100 shares valued at $262.5K.
No significant insider buying has been recorded for ONXX in the recent period.
No significant insider selling has been recorded for ONXX in the recent period.
Based on recent SEC filings, insider sentiment for ONXX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$126.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ONYX PHARMACEUTICALS INC (ONXX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading ONXX stock, having executed 959 transactions in the past 90 days. The most active insider is N. Anthony Coles (Executive), who has made 46 transactions totaling $56.5M.
Get notified when executives and directors at ONXX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 1, 2013 | Goddard Paul | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | Goddard Paul | Executive | Tender | 12,790 | $125.00 | $1.6M | Large |
| Oct 1, 2013 | Lasowski Juergen | Executive | Disposition | 30,250 | $125.00 | $3.8M | Large |
| Oct 1, 2013 | Lasowski Juergen | Executive | Tender | 1,833 | $125.00 | $229.1K | |
| Oct 1, 2013 | G. Wiggans Thomas | Executive | Tender | 6,015 | $125.00 | $751.9K | Large |
| Oct 1, 2013 | G. Wiggans Thomas | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | H. Nevinny Corinne | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | Torley Helen | Executive | Tender | 7,336 | $125.00 | $917.0K | Large |
| Oct 1, 2013 | Torley Helen | Executive | Disposition | 28,575 | $125.00 | $3.6M | Large |
| Oct 1, 2013 | Lundberg Magnus | Executive | Tender | 12,116 | $125.00 | $1.5M | Large |
| Oct 1, 2013 | Lundberg Magnus | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | Antonio J. Grillo Lopez | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | R. Ringo William | Executive | Disposition | 2,100 | $125.00 | $262.5K | |
| Oct 1, 2013 | R. Ringo William | Executive | Tender | 7,737 | $125.00 | $967.1K | Large |
| Oct 1, 2013 | Anthony Coles N. | Executive | Tender | 25,632 | $125.00 | $3.2M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 494 | $126.6M | 56.0% |
Exercise(M) | 272 | $46.8M | 20.7% |
Disposition(D) | 33 | $37.5M | 16.6% |
Tender(U) | 13 | $14.2M | 6.3% |
Payment(F) | 12 | $669.9K | 0.3% |
Purchase(P) | 2 | $72.1K | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Award(A) | 129 | $0 | 0.0% |
Insider selling pressure at ONYX PHARMACEUTICALS INC has increased, with 29 insiders executing 959 transactions across all time. Total sales of $126.6M significantly outpace purchases of $72.1K, resulting in a net outflow of $126.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.